Literature DB >> 18159540

The prevalence of hepatitis A in children in British Columbia.

Jan J Ochnio1, David W Scheifele, Murray Fyfe, Mark Bigham, David Bowering, Paul Martiquet, Margaret Ho, Douglas N Talling.   

Abstract

BACKGROUND: The risk of hepatitis A virus (HAV) infection during childhood is difficult to estimate without population serosurveys because HAV-related symptoms are often mild at this age. Few serosurveys have been conducted in Canada. The present study surveyed teenagers in two nonurban regions of British Columbia where the historical rate of reported HAV either exceeded (region A) or was less than (region B) the historical provincial rate.
METHODS: A point prevalence survey of salivary HAV-specific immunoglobulin G was conducted in high schools among grade 9 students in regions A and B. A questionnaire was used to gather sociodemographic data. The survey was extended to grade 1 and grade 5 students in community 1 of region B. Associations between risk factors and prior infection were evaluated by logistic regression.
RESULTS: Eight hundred eleven grade 9 students were tested. Antibody to HAV was detected in 4.7% of students in region A (95% CI 2.9% to 7.2%) and 9.6% of students in region B (95% CI 6.9% to 12.9%). The region B figure reflected HAV antibody prevalence rates of 19.5% in community 1 and 2.5% in the remainder of the region. Younger students in community 1 had low HAV antibody to HAV prevalence rates (3.9% for grade 1 and 3.1% for grade 5), and positive tests in this community were associated with a particular school, foreign travel and brief residence. The risk factors for HAV infection in grade 9 students were not determined.
CONCLUSIONS: Children in nonurban areas of British Columbia are generally at low risk of HAV infection during the first decade of life regardless of the reported population rates, thereby permitting the consideration of school-based HAV immunization programs.

Entities:  

Keywords:  Children; Hepatitis A; Prevalence; Saliva

Year:  2005        PMID: 18159540      PMCID: PMC2095024          DOI: 10.1155/2005/460983

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  20 in total

Review 1.  Changing epidemiology and clinical aspects of hepatitis A.

Authors:  A Forbes; R Williams
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

2.  Hepatitis A outbreak in British Columbia, 1988-1989.

Authors:  T Ng; J D Farley; R G Mathias; D Cook; J Bardsley; A Jin
Journal:  Can Dis Wkly Rep       Date:  1989-08-12

3.  Intravenous drug use and hepatitis A: an investigation of an outbreak.

Authors:  A Jin; J Bardsley
Journal:  Can J Public Health       Date:  1990 Jan-Feb

4.  National Advisory Committee on Immunization (NACI). Statement on the prevention of hepatitis A infections.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1994-08-30

5.  Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs.

Authors:  J J Ochnio; D Patrick; M Ho; D N Talling; S R Dobson
Journal:  CMAJ       Date:  2001-08-07       Impact factor: 8.262

6.  Effectiveness of a mass hepatitis A vaccination program in preadolescents.

Authors:  Angela Domínguez; Lluís Salleras; Glòria Carmona; Juan Batalla
Journal:  Vaccine       Date:  2003-01-30       Impact factor: 3.641

Review 7.  Risk groups for hepatitis A virus infection.

Authors:  Elisabetta Franco; Cristina Giambi; Rita Ialacci; Rosa C Coppola; Alessandro R Zanetti
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

8.  Sibship size as a risk factor for hepatitis A infection.

Authors:  M S Green; Y Zaaide
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

9.  Distribution of antibody to hepatitis a antigen in urban adult populations.

Authors:  W Szmuness; J L Dienstag; R H Purcell; E J Harley; C E Stevens; D C Wong
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

10.  The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies.

Authors:  B P Bell; C N Shapiro; M J Alter; L A Moyer; F N Judson; K Mottram; M Fleenor; P L Ryder; H S Margolis
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

View more
  2 in total

1.  Participant-collected, mail-delivered oral fluid specimens can replace traditional serosurveys: a demonstration-of-feasibility survey of hepatitis A virus-specific antibodies in adults.

Authors:  Jan J Ochnio; David W Scheifele; Stephen A Marion; Mark Bigham; David M Patrick; Margaret Ho; Michelle Mozel
Journal:  Can J Public Health       Date:  2007 Jan-Feb

Review 2.  Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review.

Authors:  Ba' Pham; Bernard Duval; Gaston De Serres; Vladimir Gilca; Andrea C Tricco; Jan Ochnio; David W Scheifele
Journal:  BMC Infect Dis       Date:  2005-07-07       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.